Open AccessSite Injection Reaction, Maculopapular Rash, and Rosacea Exacerbation after COVID-19 Vaccination
Author(s) -
Younes Benyamna,
Farah Marraha,
Ibtissam Al Faker,
Hanane Chahoub,
Najlae Rahmani,
Yasmine Rkiek,
Soukayna Kabbou,
Driss Soussi Tanani,
S. Gallouj
Publication year - 2022
Publication title -
case reports in dermatological medicine
Language(s) - English
Resource type - Journals
eISSN - 2090-6471
pISSN - 2090-6463
DOI - 10.1155/2022/9944727
Subject(s) - medicine , maculopapular rash , exacerbation , exanthem , dermatology , vaccination , rosacea , mucocutaneous zone , rash , adverse effect , erythema , immunology , pathology , disease , acne
To date, the occurrence of adverse events following immunization after COVID-19 vaccine is rare, and their report is still very poor; however, causality assessment is conducted to identify the associated cause, if they occur. In this case report, we present a case of an association of three cutaneous manifestations (maculopapular exanthem with enanthem, site injection reaction, and rosacea exacerbation) occurring three days after taking the first dose of AstraZeneca AZD1222 vaccine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom